Vaccines, Blood & Biologics
Officer List Memo, February 8, 2012 - Octaplas
To: The File
Date: February 8, 2012
BLA: STN 125416/0
Sponsor: Octapharma Pharmazeuticka Produktiosges.m.b.
Product: Pooled Plasma (Human), Solvent/Detergent Treated
From: Pratibha Rana
Section 916 of the Food and Drug Administration Amendments Act (FDAAA) requires that the identity of each employee or officer who participated in the decision to approve an original application be listed and filed as part of the Action Package for that file.
The following employees and officers have consented to have their names published publicly as being a participant in the approval decision for this file.
Mitchell M Frost
Mikhail V Ovanesov,
Michael (Keith) Wyatt